197 related articles for article (PubMed ID: 34463268)
1. Hidden pharmacological activities of valproic acid: A new insight.
Singh D; Gupta S; Verma I; Morsy MA; Nair AB; Ahmed AF
Biomed Pharmacother; 2021 Oct; 142():112021. PubMed ID: 34463268
[TBL] [Abstract][Full Text] [Related]
2. Biochemical, molecular and epigenetic mechanisms of valproic acid neuroprotection.
Monti B; Polazzi E; Contestabile A
Curr Mol Pharmacol; 2009 Jan; 2(1):95-109. PubMed ID: 20021450
[TBL] [Abstract][Full Text] [Related]
3. HDAC inhibition through valproic acid modulates the methylation profiles in human embryonic kidney cells.
Ganai SA; Kalladi SM; Mahadevan V
J Biomol Struct Dyn; 2015; 33(6):1185-97. PubMed ID: 25012937
[TBL] [Abstract][Full Text] [Related]
4. A proapoptotic effect of valproic acid on progenitors of embryonic stem cell-derived glutamatergic neurons.
Fujiki R; Sato A; Fujitani M; Yamashita T
Cell Death Dis; 2013 Jun; 4(6):e677. PubMed ID: 23788034
[TBL] [Abstract][Full Text] [Related]
5. Valproic acid selectively suppresses the formation of inhibitory synapses in cultured cortical neurons.
Kumamaru E; Egashira Y; Takenaka R; Takamori S
Neurosci Lett; 2014 May; 569():142-7. PubMed ID: 24708928
[TBL] [Abstract][Full Text] [Related]
6. Valproic Acid Limits Pancreatic Recovery after Pancreatitis by Inhibiting Histone Deacetylases and Preventing Acinar Redifferentiation Programs.
Eisses JF; Criscimanna A; Dionise ZR; Orabi AI; Javed TA; Sarwar S; Jin S; Zhou L; Singh S; Poddar M; Davis AW; Tosun AB; Ozolek JA; Lowe ME; Monga SP; Rohde GK; Esni F; Husain SZ
Am J Pathol; 2015 Dec; 185(12):3304-15. PubMed ID: 26476347
[TBL] [Abstract][Full Text] [Related]
7. Valproate attenuates the proteinuria, podocyte and renal injury by facilitating autophagy and inactivation of NF-κB/iNOS signaling in diabetic rat.
Khan S; Jena G; Tikoo K; Kumar V
Biochimie; 2015 Mar; 110():1-16. PubMed ID: 25572918
[TBL] [Abstract][Full Text] [Related]
8. Targeting AML1/ETO-histone deacetylase repressor complex: a novel mechanism for valproic acid-mediated gene expression and cellular differentiation in AML1/ETO-positive acute myeloid leukemia cells.
Liu S; Klisovic RB; Vukosavljevic T; Yu J; Paschka P; Huynh L; Pang J; Neviani P; Liu Z; Blum W; Chan KK; Perrotti D; Marcucci G
J Pharmacol Exp Ther; 2007 Jun; 321(3):953-60. PubMed ID: 17389244
[TBL] [Abstract][Full Text] [Related]
9. In Vitro Effect of the Histone Deacetylase Inhibitor Valproic Acid on Viability and Apoptosis of the PLC/PRF5 Human Hepatocellular Carcinoma Cell Line.
Sanaei M; Kavoosi F; Roustazadeh A; Shahsavani H
Asian Pac J Cancer Prev; 2018 Sep; 19(9):2507-2510. PubMed ID: 30256044
[TBL] [Abstract][Full Text] [Related]
10. Valproic Acid Improves Glucose Homeostasis by Increasing Beta-Cell Proliferation, Function, and Reducing its Apoptosis through HDAC Inhibition in Juvenile Diabetic Rat.
Khan S; Jena G
J Biochem Mol Toxicol; 2016 Sep; 30(9):438-46. PubMed ID: 27079868
[TBL] [Abstract][Full Text] [Related]
11. Valproic acid-mediated neuroprotection in retinal ischemia injury via histone deacetylase inhibition and transcriptional activation.
Zhang Z; Qin X; Tong N; Zhao X; Gong Y; Shi Y; Wu X
Exp Eye Res; 2012 Jan; 94(1):98-108. PubMed ID: 22143029
[TBL] [Abstract][Full Text] [Related]
12. Valproic acid enhances neuronal differentiation of sympathoadrenal progenitor cells.
Vukićević V; Qin N; Balyura M; Eisenhofer G; Wong ML; Licinio J; Bornstein SR; Ehrhart-Bornstein M
Mol Psychiatry; 2015 Aug; 20(8):941-50. PubMed ID: 25707399
[TBL] [Abstract][Full Text] [Related]
13. Histone deacetylase inhibitors, valproic acid and trichostatin-A induce apoptosis and affect acetylation status of p53 in ERG-positive prostate cancer cells.
Fortson WS; Kayarthodi S; Fujimura Y; Xu H; Matthews R; Grizzle WE; Rao VN; Bhat GK; Reddy ES
Int J Oncol; 2011 Jul; 39(1):111-9. PubMed ID: 21519790
[TBL] [Abstract][Full Text] [Related]
14. Molecular and therapeutic potential and toxicity of valproic acid.
Chateauvieux S; Morceau F; Dicato M; Diederich M
J Biomed Biotechnol; 2010; 2010():. PubMed ID: 20798865
[TBL] [Abstract][Full Text] [Related]
15. Sodium valproate ameliorates diabetes-induced fibrosis and renal damage by the inhibition of histone deacetylases in diabetic rat.
Khan S; Jena G; Tikoo K
Exp Mol Pathol; 2015 Apr; 98(2):230-9. PubMed ID: 25576297
[TBL] [Abstract][Full Text] [Related]
16. Could valproic acid be an effective anticancer agent? The evidence so far.
Brodie SA; Brandes JC
Expert Rev Anticancer Ther; 2014 Oct; 14(10):1097-100. PubMed ID: 25017212
[TBL] [Abstract][Full Text] [Related]
17. Valproic acid, a histone deacetylase inhibitor, induces apoptosis in breast cancer stem cells.
Aztopal N; Erkisa M; Erturk E; Ulukaya E; Tokullugil AH; Ari F
Chem Biol Interact; 2018 Jan; 280():51-58. PubMed ID: 29225137
[TBL] [Abstract][Full Text] [Related]
18. Exploring the Drug Repurposing Versatility of Valproic Acid as a Multifunctional Regulator of Innate and Adaptive Immune Cells.
Soria-Castro R; Schcolnik-Cabrera A; Rodríguez-López G; Campillo-Navarro M; Puebla-Osorio N; Estrada-Parra S; Estrada-García I; Chacón-Salinas R; Chávez-Blanco AD
J Immunol Res; 2019; 2019():9678098. PubMed ID: 31001564
[TBL] [Abstract][Full Text] [Related]
19. Targeting of histone deacetylases to reactivate tumour suppressor genes and its therapeutic potential in a human cervical cancer xenograft model.
Feng D; Wu J; Tian Y; Zhou H; Zhou Y; Hu W; Zhao W; Wei H; Ling B; Ma C
PLoS One; 2013; 8(11):e80657. PubMed ID: 24260446
[TBL] [Abstract][Full Text] [Related]
20. Exploring the inhibitory activity of valproic acid against the HDAC family using an MMGBSA approach.
Sixto-López Y; Bello M; Correa-Basurto J
J Comput Aided Mol Des; 2020 Aug; 34(8):857-878. PubMed ID: 32180123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
